|1.||Kitagawa, Hiroshi: 6 articles (12/2015 - 05/2003)|
|2.||White, Emily: 6 articles (01/2015 - 05/2009)|
|3.||Salanti, Ali: 5 articles (01/2015 - 07/2003)|
|4.||Lampe, Johanna W: 5 articles (01/2015 - 09/2011)|
|5.||Fawcett, James W: 5 articles (01/2012 - 04/2002)|
|6.||Reda, Domenic J: 5 articles (08/2010 - 02/2004)|
|7.||Theander, Thor G: 4 articles (01/2015 - 07/2003)|
|8.||Kantor, Elizabeth D: 4 articles (01/2015 - 12/2012)|
|9.||Venkatesan, Narayanan: 4 articles (03/2014 - 08/2006)|
|10.||Klüppel, Michael: 4 articles (01/2014 - 01/2010)|
01/01/2015 - "More high-quality studies are needed to explore the role of chondroitin in the treatment of osteoarthritis. "
06/01/2010 - "A preliminary study using this model suggests a beneficial effect of chondroitin sulphate (CS), a drug recommended for the treatment of osteoarthritis, in controlling AT lesions. "
04/17/2007 - "Studies were included if they were randomized or quasi-randomized, controlled trials that compared chondroitin with placebo or with no treatment in patients with osteoarthritis of the knee or hip. "
02/01/2005 - "The aim of this study was to evaluate histologically the action of chondroitin sulphate in osteoarthritis experimentally induced by continuous immobilization. "
01/01/2005 - "To study chondroitin sulphate (CS) efficacy, tolerance and response duration in elderly patients with osteoarthrosis (OA) with consideration of OA duration and stage. "
05/01/2007 - "This study failed to show an efficacy of chondroitin sulphate on the two primary criteria considered together, although chondroitin sulphate was slightly more effective than placebo on pain, OMERACT-OARSI response rate, investigator's assessment and quality of life."
07/14/2003 - "Chondroitin was found to be effective on Lequesne Index, visual analog scale pain, mobility, and responding status. "
05/01/2007 - "At the end of treatment, the decrease in pain was -26.2 (24.9) and -19.9 (23.5) mm and improved function was -2.4 (3.4) (-25%) and -1.7 (3.3) (-17%) in the chondroitin sulphate and placebo groups, respectively (p = 0.029 and 0.109). "
01/01/2015 - " beneficial effects of chondroitin in pain and Lequesne's index persisted when evidence was limited to studies with adequate blinding or studies that used appropriate intention to treat (ITT) analyses. These beneficial effects were uncertain when we limited data to studies with appropriate allocation concealment or a large study sample (> 200) or to studies without pharmaceutical funding. "
01/01/2015 - "Participants treated with chondroitin achieved statistically significantly and clinically meaningful better pain scores (0-100) in studies less than 6 months than those given placebo with an absolute risk difference of 10% lower (95% confidence interval (CI), 15% to 6% lower; number needed to treat (NNT) = 5 (95% CI, 3 to 8; n = 8 trials) (level of evidence, low; risk of bias, high); but there was high heterogeneity between the trials (T(2) = 0.07; I(2) = 70%, which was not easily explained by differences in risk of bias or study sample size). "
01/01/2013 - "Evaluation of the efficacy and safety of a single oral dose of a 1200 mg sachet of chondroitin 4&6 sulfate (CS 1200) vs three daily capsules of chondroitin 4&6 sulfate 400 mg (CS 3*400) (equivalence study) and vs placebo (superiority study) during 3 months, in patients with knee osteoarthritis (OA). "
05/01/2007 - "A 24-week, randomised placebo-controlled trial of chondroitin sulphate (1 g/day) in patients with symptomatic knee osteoarthritis as measured on a visual analogue scale. "
05/01/2007 - "Effect of chondroitin sulphate in symptomatic knee osteoarthritis: a multicentre, randomised, double-blind, placebo-controlled study."
05/01/1998 - "The aim of this study was to assess the clinical, radiological and biological efficacy and tolerability of the SYSADOA, chondroitin 4- and 6-sulfate (CS, Condrosulf, IBSA, Lugano, Switzerland), in patients suffering from knee osteoarthritis. "
01/01/2013 - "Equivalence of a single dose (1200 mg) compared to a three-time a day dose (400 mg) of chondroitin 4&6 sulfate in patients with knee osteoarthritis. "
|4.||Interstitial Cystitis (Interstitial Cystitis, Chronic)
01/01/2009 - "A real-life multicentre clinical practice study to evaluate the efficacy and safety of intravesical chondroitin sulphate for the treatment of interstitial cystitis."
10/01/2015 - "Intravesical chondroitin sulphate for interstitial cystitis/painful bladder syndrome."
05/01/2013 - "Efficacy of intravesical chondroitin sulphate in treatment of interstitial cystitis/bladder pain syndrome (IC/BPS): Individual patient data (IPD) meta-analytical approach."
01/01/2009 - "To report a multicentre, community based open-label study designed to assess the efficacy and safety of intravesical sodium chondroitin sulphate in the treatment of patients with the clinical diagnosis of interstitial cystitis (IC). "
01/01/2014 - "Twenty-four Wistar female rats were assigned to control (C), interstitial cystitis (IC), chondroitin sulphate (CS) and colchicine (Col) groups. "
06/01/2008 - "Effect of chondroitin sulphate in a rabbit model of atherosclerosis aggravated by chronic arthritis."
08/01/2010 - "A 24-month, double-blind, placebo-controlled study, conducted at nine sites in the US ancillary to the Glucosamine/chondroitin Arthritis Intervention Trial, enrolled 662 patients with knee OA who satisfied radiographic criteria (Kellgren/Lawrence grade 2 or 3 changes and baseline joint space width of at least 2 mm). "
11/01/2009 - "Methodology and statistical analysis in the Glucosamine/Chondroitin Arthritis Intervention Trial: comment on the article by Sawitzke et al."
10/01/2008 - "A 24-month, double-blind, placebo-controlled study, conducted at 9 sites in the United States as part of the Glucosamine/Chondroitin Arthritis Intervention Trial (GAIT), enrolled 572 patients with knee OA who satisfied radiographic criteria (Kellgren/Lawrence [K/L] grade 2 or grade 3 changes and JSW of at least 2 mm at baseline). "
01/01/2008 - "The NIH Glucosamine/Chondroitin Arthritis Intervention Trial (GAIT)."
|2.||Hyaluronic Acid (Hyaluronan)
|3.||Chondroitin Sulfates (Chondroitin Sulfate)
|6.||Collagen Type II (Type II Collagen)
|3.||Drug Therapy (Chemotherapy)